Y. Maeda et al. / Tetrahedron 60 (2004) 9031–9036
9035
(d, JZ2.4 Hz, 1H), 3.15 (br s, 1H (OH)), 3.88 (s, 3H), 5.69
(d, JZ2.4 Hz, 1H), 6.90 (d, JZ8.3 Hz, 1H), 6.97 (td, JZ
8.3, 1.5 Hz, 1H), 7.31 (td, JZ7.8, 1.5 Hz, 1H), 7.56 (dd, JZ
7.8, 1.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) d 55.5, 60.9,
74.0, 83.0, 110.7, 120.7, 127.7, 128.1, 129.7, 156.5.
20 mL Schlenk flask was added a propargylic alcohol
(0.5 mmol). Oxygen gas was then introduced into the flask
from an O2 balloon under atmospheric pressure and then the
mixture was stirred vigorously for 20 h at 100 8C under
oxygen. After the reaction, the mixture was cooled to room
temperature and CPVAP was separated by filtration through
a glass filter. The amount of the product was determined by
GLC analysis using bibenzyl as an internal standard. For
isolation of the product the solvent was evaporated and the
residue was purified by column chromatography on SiO2 (n-
4.2.3. 1-(3-Chlorophenyl)-2-propyn-1-ol.11 (1e, Table 3,
entry 6) Yellow oil; 1H NMR (400 MHz, CDCl3) d 2.37 (br
s, 1H (OH)), 2.70 (d, JZ2.2 Hz, 1H), 4.54 (d, JZ2.2 Hz,
1H), 7.31–7.44 (m, 3H), 7.56 (s, 1H); 13C NMR (100 MHz,
CDCl3) d 63.7, 75.3, 82.7, 124.6, 126.7, 128.6, 129.8, 134.4,
141.7.
1
hexane–ethyl acetate as an eluent) and identified by H
NMR and 13C NMR.
4.4.1. 1-(o-Tolyl)-2-propyn-1-one.13 (2c, Table 3, entry 4)
Yellow oil; 1H NMR (400 MHz, CDCl3) d 2.63 (s, 3H), 3.38
(s, 1H), 7.27 (d, JZ7.1 Hz, 1H), 7.35 (t, JZ7.1 Hz, 1H),
7.48 (td, JZ7.5, 1.5 Hz, 1H), 8.27 (dd, JZ7.5, 1.1 Hz, 1H);
13C NMR (100 MHz, CDCl3) d 22.1, 79.5, 81.6, 125.9,
132.1, 133.2, 133.7, 134.6, 140.8, 178.7 (C]O).
4.2.4. 1-(m-Tolyl)-2-propyn-1-ol.9 (1f, Table 3, entry 7)
Yellow oil; 1H NMR (400 MHz, CDCl3) d 2.37 (s, 3H), 2.37
(br s, 1H (OH)), 2.65 (d, JZ2.4 Hz, 1H), 5.41 (s, 1H), 7.15
(d, JZ7.3 Hz, 1H), 7.25–7.36 (m, 3H); 13C NMR
(100 MHz, CDCl3) d 21.4, 64.4, 74.7, 85.6, 123.6, 127.2,
128.5, 129.2, 138.3, 139.8.
4.4.2. 1-(2-Methoxyphenyl)-2-propyn-1-one.14 (2d, Table
3, entry 5) Yellow oil; 1H NMR (400 MHz, CDCl3) d 3.39
(s, 1H), 3.93 (s, 3H), 7.00–7.06 (m, 2H), 7.55 (ddd, JZ8.3,
7.3, 2.0 Hz, 1H), 8.06 (dd, JZ7.8, 2.0 Hz, 1H); 13C NMR
(100 MHz, CDCl3) d 55.8, 79.3, 82.1, 112.1, 120.1, 125.7,
133.1, 135.4, 159.9, 175.8 (C]O).
4.2.5. 1-(4-Chlorophenyl)-2-propyn-1-ol.10 (1g, Table 3,
entry 8) Yellow oil; 1H NMR (400 MHz, CDCl3) d 2.37 (d,
JZ2.4 Hz, 1H), 2.87 (br s, 1H (OH)), 5.40 (d, JZ2.4 Hz,
1H), 7.33 (dt, JZ8.3, 2.2 Hz, 2H), 7.45 (dt, JZ8.3, 2.2 Hz,
2H); 13C NMR (100 MHz, CDCl3) d 63.5, 75.1, 83.0, 127.8,
128.6, 134.2, 138.3.
4.4.3. 1-(3-Chlorophenyl)-2-propyn-1-one.15 (2e, Table 3,
entry 6) Orange oil; 1H NMR (400 MHz, CDCl3) d 3.49 (s,
1H), 7.45 (t, JZ7.8 Hz, 1H), 7.61 (ddd, JZ7.8, 2.0, 1.0 Hz,
1H), 8.04 (td, JZ7.8, 1.0 Hz, 1H), 8.12 (t, JZ2.0 Hz, 1H);
13C NMR (100 MHz, CDCl3) d 79.8, 81.5, 127.7, 129.5,
129.9, 134.3, 135.0, 137.4, 175.8 (C]O).
4.3. General procedure for the preparation of calcium
phosphate-vanadate apatite (CPVAP)
Calcium
phosphate-vanadate
apatite
(CPVAP)
Ca10(PO4)6Kx(VO4)x(OH)2 (xZ3.1) was prepared by fol-
lowing the method described by Boechat et al.7 To a
solution of Ca(NO3)2$4H2O (15.8 g, 66.7 mmol) in H2O
(60 mL) in a 500 mL three-necked round bottomed flask
was added a solution of VCl3 (8.6 g, 54.4 mmol) in H2O
(brown solution, 30 mL). The mixture was then brought to
pH 11–12 with 28% ammonia solution in H2O (dark brown
solution) and thereafter diluted to 120 mL. In a separate
flask, a solution of (NH4)2HPO4 (5.3 g, 40.0 mmol) in H2O
(100 mL) was brought to pH 11–12 with 28% ammonia
solution in H2O and then diluted to 160 mL. This
(NH4)2HPO4 solution was added dropwise from dropping
funnel to the above Ca(NO3)2/VCl3 solution with stirring for
30 min. After the addition, the mixture was heated to 95 8C
for 10 min. After cooling, it was filtered and the separated
solid was washed with water (20 mL!7). This solid was
dried at 80 8C for 15 h and calcined at 500 8C for 3 h to give
9.1 g of CPVAP as a pale brown solid. The vanadium
content in the CPVAP was 2.9 mmol gK1 estimated by ICP
atomic emission analysis.
4.4.4. 1-(m-Tolyl)-2-propyn-1-one.14 (2f, Table 3, entry
7) Yellow oil; H NMR (400 MHz, CDCl3) d 2.43 (s, 3H),
1
3.42 (s, 1H), 7.39 (t, JZ7.8 Hz, 1H), 7.45 (d, JZ7.8 Hz,
1H), 7.95 (s, 1H), 7.98 (d, JZ7.8 Hz, 1H); 13C NMR
(100 MHz, CDCl3) d 21.3, 80.3, 80.5, 127.1, 128.5, 129.9,
135.2, 136.1, 138.5, 177.4 (C]O).
4.4.5. 1-(4-Chlorophenyl)-2-propyn-1-one.15 (2g, Table
3, entry 8) Orange solid; mp: 96.0–97.0 8C; 1H NMR
(400 MHz, CDCl3) d 3.47 (s, 1H), 7.48 (dt, JZ8.8, 2.0 Hz,
2H), 8.10 (dt, JZ8.8, 2.0 Hz, 2H); 13C NMR (100 MHz,
CDCl3) d 79.9, 81.2, 129.0, 130.9, 134.4, 141.1, 175.9
(C]O).
4.5. General procedure for recycling of the catalyst
Recovered CPVAP by filtration from the former run of the
oxidation of porpargylic alcohols was washed with diethyl
ether and dried under vacuum at room temperature before
use for the next run.
Hydroxyapatite-supported vanadium, ruthenium and palla-
dium were prepared by treatment of hydroxyapatite
(HAP)12 with VCl3, RuCl3 and PdCl2(MeCN)2 at room
temperature in water or acetone by following the methods
described by Kaneda et al.3a,c,8
Acknowledgements
4.4. General procedure for the CPVAP-catalyzed
oxidation of porpargylic alcohols with molecular oxygen
We thank Professor Masashi Inoue and Dr. Shinji Iwamoto
(Kyoto University) for their help in ICP atomic emission
analysis to measure vanadium contents in CPVAP. The
financial support from Japan Science and Technology
Corporation (JST) is also acknowledged.
To a suspension of CPVAP (50 mg, 0.15 mmol as
vanadium) in benzonitrile or n-butyronitrile (1 mL) in a